Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates

Company Performance - Rapid Micro Biosystems reported a quarterly loss of $0.26 per share, slightly better than the Zacks Consensus Estimate of a loss of $0.27, and an improvement from a loss of $0.31 per share a year ago, representing an earnings surprise of 3.70% [1] - The company posted revenues of $7.21 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 9.17%, and showing a year-over-year increase from $5.61 million [2] - Over the last four quarters, Rapid Micro Biosystems has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - Rapid Micro Biosystems shares have increased approximately 172.2% since the beginning of the year, contrasting with the S&P 500's decline of -3.7% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.26 on revenues of $7.85 million, and for the current fiscal year, it is -$0.99 on revenues of $33.1 million [7] Industry Outlook - The Medical - Instruments industry, to which Rapid Micro Biosystems belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5]